BONNIE CRAMER: Open Payments
NPI 1679120588 · INDIANA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$998 in 49 payments from 14 companies in 2025. Trend: 2023 $214 · 2024 $720 · 2025 $998
Food & beverage: $998
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $301 |
| Ardelyx, Inc. | 12 | $189 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $99 |
| Janssen Biotech, Inc. | 2 | $75 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $59 |
| GENZYME CORPORATION | 2 | $42 |
| Madrigal Pharmaceuticals | 2 | $41 |
| Celltrion USA Inc. | 2 | $38 |
| Lilly USA, LLC | 2 | $38 |
| Intercept Pharmaceuticals, Inc. | 2 | $33 |
Products named: RINVOQ, IBSRELA, TREMFYA, ENTYVIO, XIFAXAN, MAVYRET, DUPIXENT, REZDIFFRA.
Industry payments across PA — which companies pay providers there.
